Allianz Asset Management GmbH Sells 120,172 Shares of Masimo Co. (MASI)
Allianz Asset Management GmbH cut its stake in shares of Masimo Co. (NASDAQ:MASI) by 20.8% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 458,132 shares of the medical equipment provider’s stock after selling 120,172 shares during the period. Allianz Asset Management GmbH owned approximately 0.89% of Masimo worth $39,656,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Fortaleza Asset Management Inc. purchased a new stake in Masimo during the 2nd quarter worth approximately $106,000. DekaBank Deutsche Girozentrale increased its holdings in Masimo by 78.3% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock worth $182,000 after purchasing an additional 925 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Masimo by 13.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,018 shares of the medical equipment provider’s stock worth $184,000 after purchasing an additional 236 shares during the last quarter. Advisor Group Inc. increased its holdings in Masimo by 38.4% during the 2nd quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock worth $216,000 after purchasing an additional 655 shares during the last quarter. Finally, Daiwa Securities Group Inc. purchased a new stake in Masimo during the 2nd quarter worth approximately $219,000. 83.74% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director Steven Barker sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total transaction of $900,000.00. Following the completion of the transaction, the director now owns 73,249 shares in the company, valued at approximately $6,592,410. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Yongsam Lee sold 18,198 shares of the business’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $88.85, for a total value of $1,616,892.30. Following the transaction, the executive vice president now owns 70,800 shares of the company’s stock, valued at approximately $6,290,580. The disclosure for this sale can be found here. Insiders sold a total of 53,074 shares of company stock valued at $4,737,245 over the last quarter. Company insiders own 16.60% of the company’s stock.
Several equities research analysts have issued reports on MASI shares. Zacks Investment Research upgraded Masimo from a “hold” rating to a “buy” rating and set a $98.00 price objective on the stock in a report on Thursday, November 2nd. Stifel Nicolaus restated a “buy” rating and set a $108.00 price objective on shares of Masimo in a report on Friday, November 3rd. BTIG Research upgraded Masimo from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Monday, August 14th. Finally, BidaskClub downgraded Masimo from a “hold” rating to a “sell” rating in a report on Thursday. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $97.17.
Shares of Masimo Co. (MASI) opened at $85.52 on Friday. Masimo Co. has a twelve month low of $62.96 and a twelve month high of $104.71. The firm has a market capitalization of $4,501.07, a P/E ratio of 33.38, a PEG ratio of 2.93 and a beta of 0.72.
Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.53 by $0.17. Masimo had a return on equity of 22.17% and a net margin of 45.83%. The business had revenue of $193.69 million during the quarter, compared to the consensus estimate of $189.01 million. During the same period in the previous year, the business earned $0.52 EPS. The business’s quarterly revenue was up 15.6% on a year-over-year basis. sell-side analysts expect that Masimo Co. will post 2.95 EPS for the current year.
Masimo Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Co. and related companies with MarketBeat.com's FREE daily email newsletter.